KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+8.2%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$652M
AUM Growth
+$652M
(-16%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-20.88%
Top 10 Holdings %
Top 10 Hldgs %
84.09%
Holding
37
New
–
Increased
10
Reduced
6
Closed
11
Top Buys
| 1 |
Celldex Therapeutics
CLDX
|
$40.4M |
| 2 |
Cogent Biosciences
COGT
|
$14.4M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$13M |
| 4 |
TSVT
2seventy bio
TSVT
|
$11.7M |
| 5 |
Vaxcyte
PCVX
|
$4.16M |
Top Sells
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $141M | 19.41% | 2,900,000 -18,237 | -0.6% | -$887K |
|
|
2
Celldex Therapeutics
CLDX
$1.47B
| $88.2M | 12.13% | 2,600,000 +1,190,549 | +84% | +$40.4M |
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $68.3M | 9.39% | 3,262,004 +56,018 | +2% | +$1.17M |
|
|
4
Vaxcyte
PCVX
$4B
| $64.9M | 8.93% | 1,300,000 +83,216 | +7% | +$4.16M |
|
|
TSVT
5
DELISTED
2seventy bio
TSVT
| $49.5M | 6.81% | 4,890,706 +1,151,734 | +31% | +$11.7M |
|
6
Vera Therapeutics
VERA
$1.38B
| $48.2M | 6.62% | 3,000,000 -372,428 | -11% | -$5.98M |
|
7
Protagonist Therapeutics
PTGX
$3.67B
| $26.9M | 3.71% | 975,298 -399,702 | -29% | -$11M |
|
8
Travere Therapeutics
TVTX
$1.56B
| $22.3M | 3.07% | 1,454,730 -108,865 | -7% | -$1.67M |
|
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $20.1M | 2.76% | 2,848,197 +1,848,197 | +185% | +$13M |
|
|
10
Cogent Biosciences
COGT
$1.69B
| $19.1M | 2.63% | 1,617,391 +1,217,417 | +304% | +$14.4M |
|
|
BNR
11
Burning Rock Biotech
BNR
$93.6M
| $18.3M | 2.52% | 8,500,000 +479,375 | +6% | +$1.03M |
|
12
Viridian Therapeutics
VRDN
$1.5B
| $16.9M | 2.32% | 709,498 +165,895 | +31% | +$3.95M |
|
13
Wave Life Sciences
WVE
$1.53B
| $14.3M | 1.96% | 3,924,602 +116,726 | +3% | +$425K |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $14.3M | 1.96% | 12,000,000 | – | – |
|
15
Liquidia Corp
LQDA
$2.38B
| $12.9M | 1.77% | 1,642,244 | – | – |
|
16
Olema Pharmaceuticals
OLMA
$375M
| $11.8M | 1.62% | 1,304,332 -707,521 | -35% | -$6.39M |
|
17
Sutro Biopharma
STRO
$72.7M
| $6.98M | 0.96% | 1,500,000 +598,164 | +66% | +$2.78M |
|
|
CNTA
18
Centessa Pharmaceuticals
CNTA
$2.25B
| $4.51M | 0.62% | 729,077 | – | – |
|
19
Puma Biotechnology
PBYI
$254M
| $1.67M | 0.23% | 473,070 | – | – |
|
20
Rhythm Pharmaceuticals
RYTM
$6.85B
| $1.53M | 0.21% | 92,602 | – | – |
|
|
CNTB
21
Connect Biopharma
CNTB
$115M
| $603K | 0.08% | 535,005 -204,644 | -28% | -$231K |
|
22
Neurogene
NGNE
$264M
| $99.6K | 0.01% | 119,966 | – | – |
|
23
Gyre Therapeutics
GYRE
$703M
| $31.6K | ﹤0.01% | 89,886 | – | – |
|
24
Arcellx
ACLX
$3.85B
| – | – | -31,336 | Closed | -$965K |
|
25
Allogene Therapeutics
ALLO
$251M
| – | – | -1,495,981 | Closed | -$7.39M |
|